De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.
Article
PubMed
PubMed Central
Google Scholar
De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138–51.
Article
PubMed
PubMed Central
Google Scholar
National Health Service England. Improving physical healthcare for people living with severe mental illness (SMI) in primary care: Guidance for CCGs. 2018. https://www.england.nhs.uk/wp-content/uploads/2018/02/improving-physical-health-care-for-smi-in-primary-care.pdf Accessed 29th October 2020.
National Mental Health Commission. Equally Well Consensus Statement: Improving the physical health and wellbeing of people living with mental illness in Australia. 2016. https://www.equallywell.org.au/wp-content/uploads/2018/12/Equally-Well-National-Consensus-Booklet-47537.pdf Accessed 29th October 2020.
Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiat. 2015;72(4):334–41.
Article
Google Scholar
Reilly S, Olier I, Planner C, Doran T, Reeves D, Ashcroft DM, et al. Inequalities in physical comorbidity: a longitudinal comparative cohort study of people with severe mental illness in the UK. BMJ Open. 2015;5(12):e009010.
Article
PubMed
PubMed Central
Google Scholar
National Institute for Health and Care Excellence. Multimorbidity: Clinical Assessment and Management (NG 56). 2016. https://www.nice.org.uk/guidance/ng56/resources/multimorbidity-clinical-assessment-and-management-pdf-1837516654789 Accessed 29th October 2020.
Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. 2013;346:f2539.
Article
PubMed
PubMed Central
Google Scholar
Naylor C, Das P, Ross S, Honeyman M, Thompson J, Gilburt H. The Kings Fund: Bringing Together Physical Health and Mental Health. 2016. https://www.kingsfund.org.uk/publications/physical-and-mental-health Accessed 29th October 2020.
Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009;66(7):713–20.
Article
PubMed
Google Scholar
Lawrence D HC, Jablensky AV. . Preventable Physical Illness in People with Mental Illness. The University of Western Australia. 2001(Online).
Baxter AJ, Harris MG, Khatib Y, Brugha TS, Bien H, Bhui K. Reducing excess mortality due to chronic disease in people with severe mental illness: meta-review of health interventions. Br J Psychiatry. 2016;208(4):322–9.
Article
PubMed
Google Scholar
Vermeulen J, van Rooijen G, Doedens P, Numminen E, van Tricht M, de Haan L. Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis. Psychol Med. 2017;47(13):2217–28.
Article
CAS
PubMed
Google Scholar
Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;11:449–68.
Article
PubMed
PubMed Central
Google Scholar
Alshehri GH, Keers RN, Ashcroft DM. Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. Drug Saf. 2017;40(10):871–86.
Article
PubMed
Google Scholar
Doherty AM, Gaughran F. The interface of physical and mental health. Soc Psychiatry Psychiatr Epidemiol. 2014;49(5):673–82.
Article
PubMed
Google Scholar
Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, et al. People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry. 2012;46(8):735–52.
Article
PubMed
Google Scholar
Morant N, Azam K, Johnson S, Moncrieff J. The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. J Ment Health. 2018;27(4):322–8.
Article
PubMed
Google Scholar
Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull. 2013;39(2):295–305.
Article
PubMed
Google Scholar
Keating D, McWilliams S, Schneider I, Hynes C, Cousins G, Strawbridge J, et al. Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode. BMJ Open. 2017;7(1):e013881.
Article
PubMed
PubMed Central
Google Scholar
Hynes C, McWilliams S, Clarke M, Fitzgerald I, Feeney L, Taylor M, et al. Check the effects: systematic assessment of antipsychotic side-effects in an inpatient cohort. Therapeutic Advances in Psychopharmacology. 2020;10:2045125320957119.
Article
PubMed
PubMed Central
Google Scholar
Royal College of Psychiatrists. Report of the National Audit of Schizophrenia (NAS) 2012. 2012. https://www.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/national-clinical-audits/ncap-library/national-audit-of-schizophrenia-document-library/nas-round-1-executive-summary.pdf?sfvrsn=670e8bee_4 Accessed 29th October 2020.
Gilbody S, Peckham E, Bailey D, Arundel C, Heron P, Crosland S, et al. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry. 2019;6(5):379–90.
Article
PubMed
PubMed Central
Google Scholar
Royal College of Psychiatrists. Healthcare Quality Improvement Partnership. National Clinical Audit of Psychosis – National Report for the Core Audit 2018. https://www.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/national-clinical-audits/ncap-library/ncap-exec-summary-report-core-audit-2018.pdf?sfvrsn=f4be1682_2 Accessed 29th October 2020.
Cooper SJ, Reynolds GP,With expert c-a, Barnes T, England E, Haddad PM, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2016;30(8):717–48.
Article
CAS
PubMed
Google Scholar
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.
Article
PubMed
Google Scholar
Boyd CMFM. Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? Public Health Rev. 2010;32:451–74.
Article
Google Scholar
World Health Organization. Medication safety in high-risk situations. World Health Organization; 2019. https://apps.who.int/iris/handle/10665/325131 Acccessed 29th October 2020.
Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(4 Suppl):61–8.
Article
PubMed
PubMed Central
Google Scholar
Royal College of Psychiatrists. Whole person care: From rhetoric to reality. Achieving parity between mental and physical health. Occasional Paper 88. 2013. https://www.drugsandalcohol.ie/19579/1/RCP_Occasional_paper_88.pdf Accessed 29th October 2020.
Fond G, Salas S, Pauly V, Baumstarck K, Bernard C, Orleans V, et al. End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database. Lancet Public Health. 2019;4(11):e583–91.
Article
PubMed
Google Scholar
Carolan A, Keating D, Strawbridge J, Ryan C. Optimising prescribing for patients with severe mental illness: the need for criteria. Evid Based Ment Health. 2019;22(4):139–41.
Article
PubMed
Google Scholar
Phull J NV. The use of a Lester Tool-based physical health app in mental health inpatient settings. Mental Health Practice. 2019;7(22(2)).
Royal Pharmaceutical Society. Medicines Optimisation: Helping patients to make the most of medicines. Good practice guidance for healthcare professionals in England. 2013. https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Policy/helping-patients-make-the-most-of-their-medicines.pdf Accessed 29th October 2020.
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.
American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.
Article
Google Scholar
Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600–7.
PubMed
Google Scholar
Barry E, O’Brien K, Moriarty F, Cooper J, Redmond P, Hughes CM, et al. PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique. BMJ Open. 2016;6(9):e012079.
Article
PubMed
PubMed Central
Google Scholar
Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, et al. The development of the PROMPT (PRescribing Optimally in Middle-aged People’s Treatments) criteria. BMC Health Serv Res. 2014;14:484.
Article
PubMed
PubMed Central
Google Scholar
Ryan C, O’Mahony D, Kennedy J, Weedle P, Cottrell E, Heffernan M, et al. Potentially inappropriate prescribing in older residents in Irish nursing homes. Age Ageing. 2012;42(1):116–20.
Article
PubMed
Google Scholar
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Article
PubMed
Google Scholar
Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72.
Article
CAS
PubMed
Google Scholar
Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310–9.
Article
PubMed
Google Scholar
Lavan AH, O’Mahony D, Gallagher P, Fordham R, Flanagan E, Dahly D, et al. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol. BMC Geriatr. 2019;19(1):40.
Article
PubMed
PubMed Central
Google Scholar
PRIMIS. PINCER National Rollout Progress Report to NHS England and the AHSN Network2020. Available from: https://www.nottingham.ac.uk/primis/documents/pincer/pincer-progress-report-july-2020.pdf.
Peek N, Gude WT, Keers RN, Williams R, Kontopantelis E, Jeffries M, et al. Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis. PLoS Med. 2020;17(10):e1003286.
Article
PubMed
PubMed Central
Google Scholar
Khawagi WY, Steinke DT, Nguyen J, Keers RN. Identifying potential prescribing safety indicators related to mental health disorders and medications: A systematic review. PLoS ONE. 2019;14(5):e0217406.
Article
CAS
PubMed
PubMed Central
Google Scholar
Keers RN, Williams SD, Vattakatuchery JJ, Brown P, Miller J, Prescott L, et al. Prevalence, nature and predictors of prescribing errors in mental health hospitals: a prospective multicentre study. BMJ Open. 2014;4(9):e006084.
Article
PubMed
PubMed Central
Google Scholar
Landis JR, Koch GG. The measurement of observer agreement for categorical data. biometrics. 1977:159–74.
Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother. 2009;43(7):1239–44.
Article
PubMed
Google Scholar
Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38(5):603–6.
Article
PubMed
Google Scholar
Dalkey NC. Delphi. Rand Corp Santa Monica CA. 1967. https://apps.dtic.mil/sti/pdfs/AD0660554.pdf Accessed 29th October 2020.
Lavan AH, Gallagher P, O’Mahony D. Inter-rater reliability of STOPPFrail [Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy] criteria amongst 12 physicians. Eur J Clin Pharmacol. 2018;74(3):331–8.
Article
PubMed
Google Scholar
Khawagi WY, Steinke DT, Nguyen J, Pontefract S, Keers RN. Development of prescribing safety indicators related to mental health disorders and medications: Modified e-Delphi study. Br J Clin Pharmacol. 2020.
Royal College of Psychiatrists Working Group for Improving the Physical Health of People with SMI. Improving the physical health of adults with severe mental illness: essential actions (OP100). Royal College of Psychiatrists. 2016. https://www.aomrc.org.uk/wp-content/uploads/2016/10/Improving_-physical_health_adults_with_SMI_essential_actions_251016-2.pdf Accessed 29th October 2020.
Burns A, Lucey JV, Strawbridge J, Clancy L, Doyle F. Prospective study of provided smoking cessation care in an inpatient psychiatric setting. J Psychosom Res. 2018;115:24–31.
Article
PubMed
Google Scholar
Lawrence W, Black C, Tinati T, Cradock S, Begum R, Jarman M, et al. ‘Making every contact count’: evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change. J Health Psychol. 2016;21(2):138–51.
Article
PubMed
Google Scholar
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205.
Article
CAS
Google Scholar
Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. bmj. 2017;357:j2099.
Cunningham R, Poppe K, Peterson D, Every-Palmer S, Soosay I, Jackson R. Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study. PLoS ONE. 2019;14(9): e0221521.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37(2):79–90.
Article
CAS
PubMed
Google Scholar
Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44(05):183–8.
Article
CAS
PubMed
Google Scholar
Purcell A, Clarke M, Maidment I. Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study. Int J Clin Pharm. 2018;40(3):543–9.
Article
PubMed
Google Scholar
Health Service Executive. VTE Prophylaxis Protocol for In-Patients aged 16 or Over with COVID-19 or Medical Conditions. 2020. https://hse.drsteevenslibrary.ie/c.php?g=679077&p=4866382#VTE%20Prophylaxis%20Protocol%20for%20In-Patients%20aged%2016%20or%20Over%20with%20COVID-19%20or%20Medical%20Conditions120 Accessed 29th October 2020.
O’Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020;13(1):15–22.
Article
CAS
PubMed
Google Scholar
Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M’Rabet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.
PubMed
PubMed Central
Google Scholar
De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011;26(3):144–58.
Article
PubMed
Google Scholar
Hernandez B, Reilly RB, Kenny RA. Investigation of multimorbidity and prevalent disease combinations in older Irish adults using network analysis and association rules. Sci Rep. 2019;9(1):14567.
Article
PubMed
PubMed Central
CAS
Google Scholar
Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, et al. Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing. 2016;45(4):535–42.
Article
PubMed
PubMed Central
Google Scholar